107228-54-6 Usage
General Description
3,6-dichloro-4-ethylpyridazine is a chemical compound with the molecular formula C7H6Cl2N2. 3,6-dichloro-4-ethylpyridazine falls under the classification of pyridazines, which are a class of organic compounds that contain a six-membered ring with two nitrogen atoms and four carbon atoms. The distinct features of this compound are the two chlorine atoms and one ethyl group attached to its pyridazine ring. The specific properties, synthesis methods, and applications of this compound mainly depend on its molecular structure and the type of reactions it can undergo. It's not widely discussed in public sources, therefore, details regarding its use, toxicity, and other characteristics might not be broadly available.
Check Digit Verification of cas no
The CAS Registry Mumber 107228-54-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,2,2 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 107228-54:
(8*1)+(7*0)+(6*7)+(5*2)+(4*2)+(3*8)+(2*5)+(1*4)=106
106 % 10 = 6
So 107228-54-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H6Cl2N2/c1-2-4-3-5(7)9-10-6(4)8/h3H,2H2,1H3
107228-54-6Relevant articles and documents
RAD51 INHIBITORS
-
Page/Page column 232-233, (2020/09/27)
This application is directed to inhibitors of RAD51 represented by the following structural formula, (I), and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS
-
Page/Page column 54, (2011/02/26)
The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The i
Fused heterocyclic compounds useful as kinase modulators
-
Page/Page column 70-71, (2010/11/26)
Compounds having the formula (1), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are usefuil as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR3, and R1, R2, R3, X and Y are as defined herein.
